Institute of Personalized Medicine - PUMA IPM

Pharmacogenomics aims at understanding how variations in the human genome affect the response to medications.

Our researchers are working to generate new knowledge, and to develop tools and algorithms that can help in personalizing medicine utilizing a patient’s genetic profile and other factors to achieve maximum therapeutic benefit with minimum toxicity.

News

Pamala Jacobson received the Sara Evans Faculty Woman Scholar/ Leader Award from the University of Minnesota Women’s Center, Office for Equity and Diversity and was honored at their Celebrating Changemakers Awards event on October 11, 2018.

This session highlighted the social and cultural challenges associated with providing care to local Native American tribes in Minnesota, who face larger health disparities than other populations. Pamala Jacobson, Professor, Experimental and Clinical Pharmacology, University of Minnesota, Anne Joseph, Wexler Professor of Medicine, Division of General Internal Medicine, University of Minnesota and Kris Rhodes, CEO, American Indian Cancer Foundation joined The Atlantic’s Steve Clemons to talk about why Minnesota is aptly positioned to do this important work in Native American tribes.

Sam CallistoSamuel is a PhD Candidate in the Experimental and Clinical Pharmacology department. During his time in the program Samuel has pursued various avenues of research related to precision medicine in neuropharmacology with a focus on anti-seizure drugs.

Debra SkaarWelocome to our newest member, Debra Skaar, PharmD, FCCM.  She is an Associate Professor in Experimental and Clinical Pharmacology.  Read her hio here. 

Weekly Genomics Scan

This weekly update features emerging roles of human genomics, testing and interventions in a wide variety of noncommunicable diseases across the life span.

Health Impact Weekly Scan

Precision Medicine Seminar Series

"Pharmacogenetic Studies in Special Populations: Lessons from Research Partnerships in the Hmong Community"
presented by Robert Straka, Pharm.D., FCCP
Professor and Head, Department of Experimental and Clinical Pharmacology
University of Minnesota
 
Friday, December 7
2 PM - 3 PM
1-451 Moos Tower (TC); 302 Heller Hall (Duluth via ITV)

Pharmacogenomics Conference

Genomic Testing to Individualize Drug Therapy

The 2018 Pharmacogenomics Confernece on June 22 was at capacity with over 310 registrants in attendance.  Topics included: cancer somatic mutations and selection of targeted therapies, emerging PGx areas.  Read about the event here

CPIC Guideline Videos

See the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Videos, taken from the PharmGKB YouTube channel.

Codeine and CYP2D6

Clopidogrel and CYP2C19

Simvastatin and SLCO1B1

Phenytoin, HLA-B and CYP2C9

Carbamazepine and HLA-B

Allopurinol and HLA-B

Abacavir and HLA-B